Trial Profile
A Phase I, placebo controlled trial of edratide (hCDR1) in patients with Systemic Lupus Erythematosus.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jan 2017
Price :
$35
*
At a glance
- Drugs Edratide (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions
- 09 Jan 2017 New trial record